Rhythm Pharmaceuticals, Inc.
RYTM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6 | $4 | $3 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $7 | $4 | $3 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 5.8% | 48.3% | -21.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 89.3% | 88.6% | 88.8% | 90.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -93.1% | -82.7% | -133.4% | -89.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -103.1% | -96.1% | -151.4% | -103.5% |
| EPS Diluted | -0.82 | -0.75 | -0.81 | -0.72 |
| % Growth | -9.3% | 7.4% | -12.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |